Search - tctmd.com

Displaying 381 - 400 of 921

Sort: Relevancy | Date

News Daily News

VISION Eyeballs Too-Low Troponin Values for MI, Injury After Cardiac Surgery

L.A. McKeown

March 04, 2022

News Daily News

Female Cardiologists Still Face Pushback as Physician-Researchers

Caitlin E. Cox

February 28, 2022

News Daily News

What Can Lp(a) Add to CAC for ASCVD Risk Prediction? New Insights

Yael L. Maxwell

February 22, 2022

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Michael O'Riordan

February 18, 2022

News Daily News

ROOBY-FS: 10-Year Data Affirm On-Pump CABG as Default Strategy

L.A. McKeown

February 18, 2022

News Daily News

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Michael O'Riordan

February 14, 2022

News Daily News

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Michael O'Riordan

February 10, 2022

News Daily News

COVID-19: TCTMD’s Dispatch for February Week 1

Todd Neale

January 31, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

News Daily News

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

Caitlin E. Cox

January 10, 2022

News Opinion Editor's Corner

The Biggest News of 2021: TCTMD’s Top 10

Shelley Wood

December 30, 2021

News Daily News

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

Michael O'Riordan

December 23, 2021

News Daily News

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

Michael O'Riordan

December 22, 2021

News Daily News

PASCAL Pinpoints Patients With Strokes Causally Related to PFO

Yael L. Maxwell

December 20, 2021

News Daily News

Risk Factors Still Matter for Patients With Zero CAC Score: MESA

Yael L. Maxwell

December 14, 2021

News Daily News

British Medical Groups Express Concern About Inclisiran Rollout

Michael O'Riordan

December 14, 2021

News Features

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

Todd Neale

December 09, 2021

News Features

US Chest Pain Guidelines Will Change Practice, Though Gaps Remain

Yael L. Maxwell

December 06, 2021

News Daily News

Another Study Links Stopping Statins to MACE in the Elderly

Shelley Wood

December 03, 2021

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

Michael O'Riordan

November 26, 2021

Advertisement

VISION Eyeballs Too-Low Troponin Values for MI, Injury After Cardiac Surgery

Female Cardiologists Still Face Pushback as Physician-Researchers

What Can Lp(a) Add to CAC for ASCVD Risk Prediction? New Insights

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

ROOBY-FS: 10-Year Data Affirm On-Pump CABG as Default Strategy

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

COVID-19: TCTMD’s Dispatch for February Week 1

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

The Biggest News of 2021: TCTMD’s Top 10

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

PASCAL Pinpoints Patients With Strokes Causally Related to PFO

Risk Factors Still Matter for Patients With Zero CAC Score: MESA

British Medical Groups Express Concern About Inclisiran Rollout

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

US Chest Pain Guidelines Will Change Practice, Though Gaps Remain

Another Study Links Stopping Statins to MACE in the Elderly

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content